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039: Genome-wide association study with blood
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Hypertension is a common disease affecting 25% of the adult popu-
lation. Different studies have suggested that approximately 33–66%
of the inter-individual variance in BP level is heritable. In order to
search for novel genetic variants associated with BP levels, we con-
ducted a genome-wide association study (GWAS) for three blood
pressure traits (SBP, DBP and HYP) in the KORA (Kooperative
Gesundheitsforschung in der Region Augsburg) S3/F3 epidemiolog-
ical cohort (n = 1,644) recruited from a general population in
Southern-Germany. Using a three stage study design, we identified
two new loci (at 16q23 and 17p13) associated with BP traits and
replicated these associations in two European populations (Germans,
Estonians). In a third population (British) we obtained consistent
effect signs but borderline p-values. The minor variants of these SNPs
reduce BP and therefore, protect from the development of hyperten-
sion (joint analysis, n = 1,900 hypertensives/4365 normotensives:
P = 5.41 9 10-8, OR = 0.73 and P = 7.42 9 10-7, OR = 0.65,
respectively). The identification of two novel loci encourages further
research to clarify the functional basis of the identified associations.
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Hypertension is a serious risk factor for myocardial infarction, heart
failure, vascular disease, stroke, and renal failure. The incidence of
hypertension and complications due to hypertension are even greater
in the African-American population. Angiotensinogen (AGT) gene
locus is associated with human essential hypertension and over-
expression of the AGT gene increases blood pressure in transgenic
mice. There are five polymorphic sites (A/G at -6, A/G at -217, T/C
at -532, A/G at -793, and T/G at -1074) in 1.2 kb promoter of the
human AGT gene. Variant -217A almost always occurs with -532T,
-793A, and -1074T and variant -217G almost always occurs with
-532C, -793G, and -1074G. Since allele -6A is the predominant allele
(frequency 0.85) in African-Americans, this population can be sub-
divided into two major haplotypes -6A:-217A (AA); -6A:-217G (AG.
The frequency of AA haplotype is significantly increased in African–
American hypertensive patients as compared to the AG haplotype.
AGT gene is primarily expressed in the liver and reporter constructs
containing AA haplotype of the AGT gene promoter have increased
promoter activity on transient transfection in human liver cells as
compared to the AG haplotype. In order to understand the role of AA
and AG haplotypes on human AGT expression in an in vivo situation,
we have generated double transgenic mice containing either haplo-
type AA or AG of the human AGT gene using knock-in strategy at
the HPRT locus and human renin gene. Our quantitative RT-PCR
analysis has shown that transgenic mice containing AA haplotype
have 1.6-fold increase in the AGT mRNA level in the liver as
compared to the transgenic mice containing AG haplotype. In addi-
tion, Western blot analysis has shown that transgenic mice containing
AA haplotype have 30% increase in the AGT protein level in the
liver as compared to transgenic mice containing AG haplotype. In
addition we show that blood pressure of 3-months-old male trans-
genic mice containing AA haplotype is increased by 7 mmHg during
the day time and 11 mMHg during the night time (n = 4 for 4 days)
as compared to the transgenic mice containing AG haplotype. To our
knowledge, this is the first report where polymorphisms in the
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promoter of a human gene have been shown to have physiological
affect in an in vivo situation.
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Tuberculosis continues to cause substantial morbidity and mortality
throughput the world, especially in developing countries where
infrastructure and access to treatment is limited. Host genetics play an
important role in tuberculosis disease as demonstrated by twin stud-
ies. Although many tuberculosis candidate gene studies have been
published many fail to replicate. We performed a genome wide
association study of tuberculosis susceptibility in a Gambian popu-
lation to determine genetic loci associated with tuberculosis disease
process. DNA was collected and genotyped for 1,498 pulmonary
tuberculosis cases and 1,496 population controls from The Gambia. In
total 429,403 SNPs were analysed to find 38 independent loci asso-
ciated with tuberculosis disease with P less than 10-4 and seven loci
with P less than 10-5. The analysis revealed that several of the
associated genes are all related to NCAM1, suggesting a role of this
gene family in the development of pulmonary tuberculosis. Replica-
tion studies are currently underway to attempt to confirm these
findings. Functional analysis of two of the loci associated with
tuberculosis has revealed differential TNF production based upon
genotype, suggesting a mechanism of protection against tuberculosis.
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Sarcoidosis is a complex chronic inflammatory disorder with pre-
dominant manifestation in the lung. In the first genome-wide
association study ([440,000 SNPs) of this disease, comprising 499
German sarcoidosis patients and 490 controls, we detected a series of
genetic associations, the most prominent being with the ‘‘SARC2’’*
gene on chromosome ten. Validation in an independent sample (1,649
cases, 1,832 controls) confirmed the association (SNP rs00*:
P = 3.0 9 1013, rs01*: P = 1.0 9 10-5, allele-based test). Extensive
fine mapping located the association signal to a region between exon
5 and 14 of SARC2. A common non-synonymous SNP (rs02*, T [ C,
p.Arg00*Cys) was found to be strongly associated with sarcoidosis.
The GWAS lead SNP and additional risk variants in the region (rs03*,
rs04*, rs05*) were in strong linkage disequilibrium with rs02*. The
SARC2 protein has complex and essential functions in several
biological pathways, including apoptosis and proliferation. We also
examined the association of SARC2 with other granulomatous dis-
eases (e.g., Crohn disease, rheumatoid arthritis). Data suggest a
potential relevance of SARC2 as a risk gene for phenotypic related
disorders and indicate it as a susceptibility locus of general
importance.
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Solid tumors can be broadly classified into two categories. Clinically
homogeneous aggressive cancers such as those of the pancreas, bil-
iary tract, liver, etc., exhibit low survival rates and patients succumb
to recurrent metastatic tumors following surgery, necessitating
development of efficient treatment strategies. On the other hand,
clinically heterogeneous cancers including those of the breast, colon,
prostate, etc., exhibit variable survival rates and tumor classification
is essential for better patient management. It is widely believed that
cancer occurs due to genetic instability leading to multiple molecular
perturbations in the genome, resulting in activation of oncogenes and
inactivation of tumor suppressor genes. In order to understand the
molecular basis for the highly aggressive pancreatic cancer, we
employed array-based Comparative Genomic Hybridization to iden-
tify recurrent copy number alterations (CNAs) that harbor important
oncogenes and tumor suppressor genes. We used genome-wide
expression profiling and real time RT-PCR to determine the subset of
genes located within the CNAs that exhibited comparably altered
expression levels. Our results revealed novel candidate oncogenes
and tumor suppressor genes involved in diverse pathways including
cell motility, apoptosis, mitochondrial oxidative phosphorylation and
chromatin remodeling. Studies are underway to characterize the role
of these genes in pancreatic cancer. In addition, we have commenced
a large scale multi-pronged molecular analysis of esophagous cancer
including characterization of known aberrations such as microsatel-
lite instability, Wnt signaling, and determination of p53 and EGFR
status and identification of novel aberrations using genomic
approaches. Results indicate important molecular differences
between adenocarcinoma (common in western countries) and squa-
mous cell carcinoma (the second most common cancer in several
population-based cancer registries of the ICMR in India) of the
esophagous (ESCC). Genomic microarray studies have identified a
novel recurrent amplicon at 10q21 in ESCC. Efforts are underway to
identify the ‘driver’ oncogene(s) resident within this amplicon.
182 Genomic Med. (2008) 2:181–183
123
Recently, we have initiated a comprehensive characterization of
sporadic and familial colorectal cancer occurring in the young, an
important problem in India. Results have revealed molecular features
in tumors occurring in young patients that are distinct from those
occurring in older patients.
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Cancer is known to have a complex etiology, with both inherited and
somatic components. Recent studies have yielded promising results
using SNPs as markers in associations studies, detecting associations
between certain SNP alleles and susceptibility to a variety of cancer
types. However, bearing in mind that somatic copy number changes
are a hallmark of cancer, we have conducted a study treating somatic
copy number lesions (representing the cancer genome) at each gene
as an phenotype, with inhertied SNP alleles (representing the
germline genome) as predictors. We have analyzed 474 lung and
breast cancer samples. For each of these samples, we posess Af-
fymetrix 250K SNP array data for both tumor DNA and matched
normal DNA. Our analysis reveals abundant cis associations between
inherited variants and somatic amplification of certain genes,
including well-known oncogenes. We also report some evidence for
trans associations. This study demonstrates that somatic amplifica-
tion may be treated as an intermediary molecular phenotype in
cancer, and that the germline genome and tumor genome may be
simultaneously interrogated in the patient to gain additional insight
into inherited cancer susceptibility.
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